China’s Alebund Pharmaceuticals announced positive top-line Phase III results highlighting that the use of AP301 demonstrated a statistically-significant and clinically-meaningful improvement in serum ...

The pharmaceutical giant sees the drug, gefurulimab, as a more convenient, self-administered alternative to the infused medicines it currently sells for  myasthenia gravis.

Upadacitinib demonstrated greater clinical efficacy and a comparable safety profile to adalimumab for treating RA, regardless of patients’ baseline CV risks.

Despite having an office with hundreds of attorneys, Ken Paxton frequently opts to hire private lawyers. One cost taxpayers ...

Mike Cernovich said the only way to fix the fallout is for the DOJ to release Jeffrey Epstein’s original arrest warrant applications ...

Securitization comprised of green bonds reflects EdgeCore’s commitment to sustainable development and operations practices DENVER, CO / ACCESS Newswire / July 24, 2025 / EdgeCore Digital ...